Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Bleeding Yankee Blue
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Rizzo And Gleyber No Mas

% of readers think this story is Fact. Add your two cents.


It’s over.

The Yankees have officially closed the book on Gleyber Torres and Anthony Rizzo, as reported by the always-reliable Jack Curry of YES Network. According to Curry, the Yankees have “no plans” to pursue either player in free agency, and while I’ve always liked both of them, this is baseball. And in baseball, tough decisions are as routine as a seventh-inning stretch.

Anthony Rizzo’s departure probably stings the most. When he arrived at the trade deadline in 2021, he felt like the perfect piece: a slick-fielding, left-handed power hitter with veteran leadership to boot. But injuries turned his Yankee tenure into a revolving door to the IL. His back gave him grief in 2022, a head injury sidelined him in 2023, and 2024 ended with a broken arm. The Yankees paid him a $6 million buyout to move on, which is logical but still tough to swallow.

First base is now a question mark. Oswaldo Cabrera is versatile but not a long-term solution, and Ben Rice—well, let’s just say his rookie slash line of .171/.264/.349 suggests he needs more seasoning. Safe to say, the Yankees will likely shop around for a new first baseman.

Then there’s Gleyber Torres, the ultimate “what could have been” story. When Torres debuted in 2018, he looked like a star in the making, and his 38-homer season in 2019 only cemented that feeling. But after that, his bat cooled off, his slugging percentage took a nosedive, and consistency became a foreign concept.

To his credit, Torres showed resilience in 2024. After a sluggish start, he adjusted during the All-Star break and hit .293 with a .361 OBP over the second half of the season. He even reclaimed the leadoff spot and performed decently in the postseason. But the Yankees decided not to extend him a qualifying offer, and now he’s gone it appears, officially according to Curry. It’s like breaking up with someone you know is talented but just isn’t right for your long-term plans.

Jack Curry’s report makes it clear that the Yankees are focusing on the future, even if it means letting go of two well-known faces. Baseball is a business, after all, and sometimes that business means saying goodbye to players you’ve rooted for.

Rizzo and Torres both leave behind memories—some great, some frustrating—but here’s hoping they find success elsewhere. Meanwhile, the Yankees have plenty of work to do this offseason, and Jack Curry will probably be the first to let us know what’s next. Stay tuned.


Source: http://bleedingyankeeblue.blogspot.com/2024/12/rizzo-and-gleyber-no-mas.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Total 1 comment
  • Anonymous

    Rizzo was a bust overall, brittle and mostly unreliable. Parting with both will be good if they pick up better defensive players who can hit.

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.